Graham Holdings Co
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Graham Holdings Co.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 949.80 $ to 1,234.00 $ · Last price: 1,133.90 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Education & Training Services
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Graham Holdings Co GHC | 4.9 | 17.4 | 5.4 | 30.0 | 9.1 | 2.5 | -0.2 |
| New Oriental Education & Technology EDU | 9.4 | 19.3 | 7.7 | 54.6 | 5.6 | 15.9 | 8.1 |
| TAL Education Group TAL | 6.6 | 7.3 | 10.2 | 56.0 | 18.1 | 34.2 | 7.6 |
| Laureate Education Inc LAUR | 5.2 | 19.1 | 9.5 | 36.8 | -10.1 | 8.6 | 20.7 |
| Covista Inc. CVSA | 4.3 | 18.6 | 10.2 | 57.3 | 18.9 | 12.9 | -7.1 |
| Grand Canyon Education Inc LOPE | 4.0 | 19.2 | 10.7 | 53.3 | 30.9 | 7.1 | -27.0 |
| Stride Inc LRN | 3.4 | 12.6 | 5.3 | 37.8 | 20.8 | 17.9 | -41.6 |
| McGraw Hill, Inc. MH | 2.5 | 68.9 | 7.1 | 81.7 | 7.1 | 0.1 | -7.2 |
| Perdoceo Education Corp PRDO | 2.1 | – | 5.2 | 79.9 | 28.5 | 24.2 | -5.5 |
| Median of companies shown | 4.3 | 18.8 | 7.7 | 54.6 | 18.1 | 12.9 | -5.5 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 2,482 | 223 | 169 | 30.16 | 261 | 2,453 | 4,433 |
| 2017 | 2,592 | 136 | 302 | 54.40 | 268 | 2,915 | 4,938 |
| 2018 | 2,696 | 246 | 271 | 50.50 | 287 | 2,917 | 4,764 |
| 2019 | 2,932 | 145 | 328 | 61.55 | 165 | 3,319 | 5,931 |
| 2020 | 2,889 | 100 | 300 | 58.45 | 211 | 3,759 | 6,444 |
| 2021 | 3,186 | 77 | 352 | 70.91 | 202 | 4,400 | 7,426 |
| 2022 | 3,924 | 84 | 67 | 13.87 | 236 | 3,731 | 6,553 |
| 2023 | 4,415 | 69 | 205 | 44.11 | 260 | 3,976 | 7,188 |
| 2024 | 4,791 | 216 | 725 | 164.50 | 407 | 4,257 | 7,677 |
| 2025 | 4,912 | 252 | 292 | 66.84 | 340 | 4,794 | 8,396 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 126.42 | 971.70 | 1,246 | 6.80 | 44.10 | 116 | 91 |
| 2025: Q1 | 5.48 | -80.40 | 1,166 | 1.10 | 2.00 | 46 | 31 |
| 2025: Q2 | 8.40 | – | 1,216 | 2.60 | 3.00 | 95 | 78 |
| 2025: Q3 | 28.08 | 69.80 | 1,279 | 5.90 | 9.60 | 178 | 162 |
| 2025: Q4 | 24.83 | -80.40 | 1,251 | 0.40 | 8.70 | 21 | -3 |
| 2026: Q1 | 6.65 | 21.30 | 1,236 | 6.00 | 2.40 | 68 | 49 |
| 2026: Q2 | 64.86 | 672.10 | 1,303 | 7.10 | 21.60 | – | – |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 9 of our scanner strategies — each hit links to the scanner.
Growth
Quality & Balance Sheet
Breakout & Setup
Momentum & Trend
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 69.00 | 69.00 – 69.00 | 5,205 | 34.0% | 1 |
| 12/31/2027 | 67.00 | 67.00 – 67.00 | 5,415 | -2.9% | 1 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly 7.9% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $240.3M |
|---|---|
| Market cap | $4.86B |
| Free cash flow in year ten | $512.1M |
| Terminal value as a share of market value | 55.5% |
For comparison: over the past five years free cash flow grew by 13.7% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 7.8%
- More than 10% revenue growth is expected for the coming year 4.0%
- Share count grows by less than 3% a year -3.3%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 8.0%
- Gross margin at 40% or higher and without meaningful erosion 27.6%
- Goodwill from acquisitions does not grow faster than revenue 18.9%
- Net debt below twice EBITDA 0.5 x EBITDA
- Operating cash flow covers the profits of the last three years -216 m
- Return on capital at 15% or higher, or up versus two years ago 3.6%
- Insiders hold at least 10% or are net buyers 7.3%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
3/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 7.9%
- Exp. sales growth 3Y > 5% 5.0%
- EBIT growth 10Y > 5% 1.4%
- Exp. EBIT growth 3Y > 5% 0.1%
- Net debt < 4x EBIT 1.5x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 71.8%
- Return on equity > 15% 9.6%
- ROCE > 15% 3.6%
- Expected return > 10% 5.6%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Maas, Jacob | Executive VP | Other | 501 | 1,159.23 | 580,774 |
| Aug 28, 2026 | Maas, Jacob | Executive VP | Other | 1,000 | 0.00 | – |
| Aug 13, 2026 | O'Shaughnessy Timothy J | President and CEO | Other | 4,211 | – | – |
| Aug 13, 2026 | O'Shaughnessy Laura | 10% Owner | Other | 4,211 | – | – |
The company
About the Company
Graham Holdings Company ist über ihre Tochtergesellschaften als diversifizierte Holdinggesellschaft in den USA und international tätig. Das Unternehmen bietet akademische Vorbereitungsprogramme für internationale Studierende; berufliche Weiterbildung und postsekundäre Bildungsdienstleistungen sowie Englisch-…
- Employees
- 12,747
- Headquarters
- Arlington, VA
- Address
- 1812 North Moore Street, 22209 Arlington, United States
- Phone
- 703 345 6300
- Website
- ghco.com
- IPO Date
- 01/24/1990
- ISIN
- US3846371041
- Stock Split
- 1655:1000 on 07/01/2015
- Stock Split
- 2:1 on 01/08/1979
- Stock Split
- 2:1 on 12/20/1976
Management
| Name | Title | Birth Year |
|---|---|---|
| Timothy J. O'Shaughnessy | President, CEO & Director | 1981 |
| Wallace R. Cooney CPA | Senior VP of Finance & CFO | 1963 |
| Nicole Marie Maddrey M.D. | Senior VP, General Counsel & Secretary | 1965 |
| Andrew Stephen Rosen | Executive Vice President | 1961 |
| Jacob M. Maas | Executive Vice President | 1977 |
| Marcel A. Snyman | VP & Chief Accounting Officer | 1975 |
| Spiro Roiniotis | VP & CTO | – |
| Sandra M. Stonesifer | Senior VP & Chief HR and Administrative Officer | 1985 |
| Matthew R. Greisler | VP & Treasurer | – |
| Dee Grein | Chief Executive Officer of Graham Healthcare Group | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.